EnWave 2026 Second Quarter Consolidated Interim Financial Results

EnWave Corporation (TSX-V:ENW | FSE:E4U) (“EnWave”, or the “Company”) today reported the Company’s consolidated interim financial results for the second quarter ended March 31, 2026.  

All values in thousands and denoted in CAD unless otherwise stated.

• Reported revenue for Q2 2026 of $1,159, representing a decrease of $2,530 relative to the comparable period in the prior year. The decrease was primarily related to fewer machine sales and machines in fabrication due to the inherent volatility in large-scale Radiant Energy Vacuum (“REV”) machine orders.
• Reported royalties, excluding exclusivity payments (“Base Royalties”), for Q2 2026 of $434, a decrease of $40, or 8% relative to the comparable period in the prior year.  Reported total royalty revenue for Q2 2026 of $465, a decrease of $9 or 2% relative to total royalty revenue in the comparable period in the prior year. Royalties decreased due to lower product sales and partner production for the quarter. The Company expects royalty revenue growth in future periods as a few partners have communicated inventory builds in anticipation of increased commercial sales activity and expanded product distribution in upcoming quarters.
• Gross margin for the three months ended Q2 2026 was 35% compared to 33% for the three months ended Q2 2025. The increase in margin was primarily attributable to lower fabrication costs from large-scale machines on contract, as compared to the prior quarter.
• Reported an increase in Selling, General & Administrative (“SG&A”) costs (including Research & Development (“R&D”)) of $78 for Q2 2026 relative to the comparable period in the prior year, with the increase primarily related to more sales personnel, the timing of patent maintenance fees and professional fees.
• Reported an Adjusted EBITDA⁽¹⁾ loss of $775 for Q2 2026, a decrease of $887 from the comparable period in the prior year.

Consolidated Financial Performance:

Note: ⁽¹⁾ Adjusted EBITDA is a non-IFRS financial measure. Refer to the Non-IFRS Financial Measures disclosure below for a reconciliation to the nearest IFRS equivalent.

EnWave’s consolidated interim financial statements and MD&A are available on SEDAR+ at www.sedarplus.ca and on the Company’s website www.enwave.net

Key Financial Highlights for the Six Months Ended March 31, 2026 (expressed in 000’s)

• Reported revenue of $2,759, a decrease of $2,107 relative to the comparable period in the prior year. The decrease was primarily related to fewer machine sales. 
• Reported Base Royalties of $934, an increase of $35 or 4% relative to the comparative period in the prior year. Reported total royalty revenues of $1,092, an increase of $59 or 5% relative to the comparative period in the prior year. Royalties grew due to increased royalty partners, product sales, partner production, and exclusivity payments.
• Reported an increase in SG&A costs of $278 for the six months ending March 31, 2026, relative to the comparable period in the prior year, with the increase primarily related to more sales personnel, patent maintenance fees, and recruitment fees. In the comparative period, legal costs associated with the Term Loan and Credit Facility were capitalized as part of the transaction.
• Reported an Adjusted EBITDA⁽¹⁾ loss of $1,360 for the six months ended March 31, 2026, a decrease of $837 from the comparable period in the prior year.

Significant Corporate Accomplishments in Q2 2026 and Subsequently:

• Signed a Technology Evaluation and License Option Agreement with one of the world’s largest multinational food companies. 
• Signed a Commercial Licence Agreement (“CLA”) and Equipment Purchase Agreement (“EPA”) for a 10kW REV^TM machine  with The Dry Hub (“DryHub”), an Egyptian food processing Company.
• Signed a Research and Development License Agreement (“RDLA”) with Rhizome Food and Farming LLC (“Rhizome”), a North American food Company led by renowned chef Dan Barber. Rhizome acquired a 3.6kW REV^TM machine for commercial and product development.
• Signed a RDLA and EPA for a 10kW REV^TM machine with Teagasc, the Agriculture and Food Development Authority of Ireland.
• Signed a CLA with Gowen Gumlu Grower’s Association (“BGGA”) in North Queensland, Australia. BGGA acquired a 10kW REV™ machine from EnWave’s Australian third-party machine re-seller, Scitek.

Medidas financieras distintas de las NIIF:

This news release refers to Adjusted EBITDA which is a non-IFRS financial measure. We define Adjusted EBITDA as earnings before deducting amortization and depreciation, stock-based compensation, foreign exchange gain or loss, finance expense or income, income tax expense or recovery, non-recurring income and expenses,  restructuring and severance charges, and discontinued operations. This measure is not necessarily comparable to similarly titled measures used by other companies and should not be construed as an alternative to net income or cash flow from operating activities as determined in accordance with IFRS. Please refer to the reconciliation between Adjusted EBITDA and the most comparable IFRS financial measure reported in the Company’s consolidated interim financial statements.

Non-IFRS financial measures should be considered together with other data prepared in accordance with IFRS to enable investors to evaluate the Company’s operating results, underlying performance and prospects in a manner similar to EnWave’s management. Accordingly, these non-IFRS financial measures are intended to provide additional information and should not be considered in isolation or as a substitute for measures of performance prepared in accordance with IFRS. For more information, please refer to the Non-IFRS Financial Measures section in the Company’s MD&A available on SEDAR+ www.sedarplus.ca.

Acerca de EnWave

EnWave es líder mundial en innovación y aplicación de la deshidratación por microondas al vacío. Desde su sede en Delta (Columbia Británica), EnWave ha desarrollado una sólida cartera de propiedad intelectual, ha perfeccionado su tecnología Radiant Energy Vacuum (REV™) y ha transformado una idea innovadora en una solución de secado probada, consistente y escalable para las industrias alimentaria, farmacéutica y del cannabis que supera ampliamente a los métodos de secado tradicionales en eficiencia, capacidad, calidad del producto y coste.

With more than fifty partners spanning twenty-four countries and five continents, EnWave’s licensed partners are creating profitable, never-before-seen snacks and ingredients, improving the quality and consistency of their existing offerings, running leaner and getting to market faster with the company’s patented technology, licensed machinery, and expert guidance.

La estrategia de EnWave consiste en firmar licencias comerciales sujetas a derechos de autor con productores de alimentos que deseen secar mejor, más rápido y de forma más económica que la liofilización, el secado en bastidor y el secado al aire, y disfrutar de las siguientes ventajas: producir productos nuevos e interesantes, alcanzar niveles óptimos de humedad hasta siete veces más rápido y mejorar el sabor, la textura, el color y el valor nutritivo del producto.

Más información en EnWave.net.

Corporación EnWave

Sr. Brent Charleton, CFA

Presidente y Consejero Delegado

Para más información:

Brent Charleton, CFA, Presidente y Director General, +1 (778) 378-9616
Correo electrónico: bcharleton@enwave.net      

Dylan Murray, CPA, CA, CFO al +1 (778) 870-0729
Correo electrónico: dmurray@enwave.net  

Safe Harbour para declaraciones de información prospectiva: Este comunicado de prensa puede contener información prospectiva basada en las expectativas, estimaciones y proyecciones de la dirección. Todas las declaraciones que se refieran a expectativas o proyecciones sobre el futuro, incluidas las declaraciones sobre la estrategia de crecimiento de la empresa, el desarrollo de productos, la posición en el mercado, los gastos previstos y las sinergias esperadas tras el cierre son declaraciones prospectivas. No se garantiza la exactitud de todas las afirmaciones de terceros a las que se hace referencia en este comunicado. No se garantiza la exactitud de todas las referencias de terceros a información de mercado contenidas en este comunicado, ya que la empresa no ha llevado a cabo la investigación primaria original. Estas afirmaciones no constituyen una garantía de resultados futuros e implican una serie de riesgos, incertidumbres y suposiciones. Aunque la empresa ha intentado identificar los factores importantes que podrían hacer que los resultados reales difirieran materialmente, puede haber otros factores que hagan que los resultados no sean los previstos, estimados o deseados. No puede garantizarse que tales afirmaciones resulten exactas, ya que los resultados reales y los acontecimientos futuros podrían diferir sustancialmente de los previstos en dichas afirmaciones. Por consiguiente, los lectores no deben depositar una confianza indebida en las afirmaciones de carácter prospectivo.

Ni la TSX Venture Exchange ni su Proveedor de Servicios de Regulación (según se define este término en las políticas de la TSX Venture Exchange) aceptan responsabilidad alguna por la adecuación o exactitud de este comunicado.